Word: smalling
(lookup in dictionary)
(lookup stats)
Dates: during 1990-1999
Sort By: most recent first
(reverse)
...brokerage services, as more customers have looked to open hybrid portfolios made up of stocks and funds. "This industry has grown so rapidly that there is a shortage of good managers," says Bridget Macaskill, CEO of Oppenheimer Funds. "But mutual funds are fundamentally a good tool for small investors...
...cyclical market that has got out of hand, rather than a fundamental, long-term shift. "It's based on a false sense of empowerment," claims funds watcher Avi Nachmany of Strategic Insight. Once the narrow bull market calms down, or broadens to include harder-to-choose value and small-cap stocks (as it appears to have done of late), Nachmany and others argue, investors will rush back to the relative safety of a diversified mutual fund. "Investors have abandoned the risk side of the equation, but it's not sustainable," says Greg Johnson, president of Franklin Templeton Distributors...
That's a little like saying the portions are too small at a four-star restaurant. But in this case, the criticism could be fatal. The unit itself retails for $599, which is supportable, I guess. But Palm's basic wireless service is $9.99 a month, which buys you 50 kilobytes, or 150 Palm-screen pages of text. I ran through that in a day. And at the end of two weeks, after consciously limiting consumption, I had used 138 kilobytes--$35.20 more than the basic charge. Even the $24.99-for-150-kilobyte, big-user plan would be inadequate...
When I was seven years old, my father announced one day that we were moving to California. My reaction and my brother's were predictable. We went into a small panic at the prospect of going to a new school and having to make new friends. Our parents, just as predictably, assured us that it would turn out to be no big deal. Now the roles are reversed, in a way. My father, who's 76, is wrestling with a decision about whether to move from the house in which he lived with my mother while she was alive into...
...This is something that does happen from time to time,? says TIME medical columnist Christine Gorman. ?Once in the marketplace, a drug is used by millions of people, but during clinical trials, it is tested on only a few thousand people. So occasionally a small risk will get missed in the trials.? Beyond highlighting the fact that safety watchdogs need to continually update the risk-benefit analysis of the drugs they approve, the Trovan incident also underscores a more ominous development. ?We are running into more and more germs that are proving resistant,? says Gorman, ?and as a result...